BIOVICA INTERNATIONAL AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.706 SEK | +6.36% |
|
-22.81% | -33.88% |
| 04-13 | Certain B Shares of Biovica International AB are subject to a Lock-Up Agreement Ending on 13-APR-2024. | CI |
| 04-12 | Biovica International AB Announces Divitum® Tka in Observational Trial | CI |
Chart calendar Biovica International AB
06e767a6765b8f6973a32f2eb3b.GlTMgcOVFRT-QAwTZdiKnU5VCtd-R_fJkNh_OQp3j1U.K2anyYSmOG2EJ3s-N-zI9H9hM5oLMZur2apJbWk57ngpIYDC8exRUohzVQ~359f4bf97f186e9681631414be7c277e
Upcoming events on Biovica International AB
Past events on Biovica International AB
| 14/03/2024 14:00 | Q3 2024 Earnings Call |
| 14/03/2024 07:00 | Q3 2024 Earnings Release |
| 06/12/2023 14:00 | Carlsquare Investor Day |
| 04/12/2023 | San Antonio Breast Cancer Symposium |
| 28/11/2023 14:00 | Q2 2024 Earnings Call |
| 28/11/2023 07:00 | Q2 2024 Earnings Release |
| 23/11/2023 13:00 | Extraordinary Shareholders Meeting |
| 06/09/2023 14:00 | Q1 2024 Earnings Call |
| 06/09/2023 07:00 | Q1 2024 Earnings Release |
| 05/09/2023 09:00 | Annual General Meeting |
| 21/06/2023 14:00 | Q4 2023 Earnings Call |
| 20/06/2023 | Q4 2023 Earnings Release Pre-market |
| 17/05/2023 12:00 | Extraordinary Shareholders Meeting |
| 17/03/2023 14:00 | Q3 2023 Earnings Call |
| 16/03/2023 07:20 | Q3 2023 Earnings Release |
| 14/12/2022 | Interim 2023 Earnings Release Pre-market |
| 08/12/2022 23:00 | San Antonio Breast Cancer Symposium - Poster P5-02-27 |
| 23/11/2022 | Redeye Life Science Day |
| 23/11/2022 05:00 | Investor Meeting |
| 21/11/2022 | SEB Healthcare Seminar |
Annual results
| Fiscal Period | April | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 3,01 3,10 -3.06% | 1,67 3,00 -44.3% | 2,08 3,00 -30.77% | 2,05 1,00 104.5% | 3,38 5,00 -32.34% | 10,0 |
|
EBITDA Million SEK | Released Forecast Spread | -18,7 -16,0 -16.86% | -25,6 -32,2 20.23% | -34,0 -34,0 -0.11% | -53,7 -48,0 -11.8% | -102 -86,5 -18.15% | -102 |
|
EBIT Million SEK | Released Forecast Spread | -21,7 -20,0 -8.59% | -29,8 -38,0 21.54% | -40,2 -40,0 -0.45% | -60,1 -55,0 -9.27% | -110 -95,0 -16.21% | -111 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -21,5 -19,0 -13.28% | -30,3 -37,7 19.74% | -39,4 -40,0 1.53% | -60,0 -45,5 -31.78% | -111 -95,0 -16.51% | -109 |
|
Net income Million SEK | Released Forecast Spread | -21,6 -19,0 -13.45% | -30,3 -28,4 -6.75% | -39,5 -40,0 1.3% | -60,0 -37,1 -61.68% | -110 -94,8 -16.59% | -110 |
|
EPS SEK | Released Forecast Spread | -1,23 -1,10 -11.82% | -1,29 -1,60 19.38% | -1,39 -1,42 2.11% | -2,11 -1,48 -42.59% | -3,18 -2,31 -37.95% | -13,0 |
| Announcement Date | 14/06/19 | 05/06/20 | 17/06/21 | 16/06/22 | 21/06/23 | - |
Quarterly results
| Fiscal Period | April | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 1,08 | 0,59 2,00 -70.65% | 1,75 2,00 -12.3% | 2,56 4,00 -35.93% | 1,08 9,00 -88.06% | 5,00 | |||
|
EBITDA Million SEK | Released Forecast Spread | -12,9 -11,1 -15.73% | -17,3 | -27,2 -20,0 -36.2% | -35,2 -23,0 -53.27% | -29,8 -28,0 -6.58% | -22,9 -26,0 11.84% | -25,5 -27,0 5.44% | -23,0 | |
|
EBIT Million SEK | Released Forecast Spread | -14,4 -11,1 -29.44% | -19,1 | -29,3 -22,0 -33.08% | -37,2 -25,0 -49.13% | -32,2 -30,0 -7.31% | -25,3 -29,0 12.7% | -27,8 -28,5 2.29% | -26,0 | |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -14,3 -11,3 -27.31% | -19,1 -14,3 -33.58% | -29,2 -22,0 -32.64% | -37,2 -23,0 -61.75% | -31,9 -25,0 -27.78% | -23,8 -32,0 25.71% | -27,6 -35,0 21.19% | -34,0 | |
|
Net income Million SEK | Released Forecast Spread | -14,3 -11,3 -27.34% | -19,1 -14,3 -33.46% | -23,3 | -28,5 -22,0 -29.72% | -37,7 -22,9 -64.29% | -32,3 -24,8 -30.04% | -25,7 -31,7 18.86% | -27,3 -35,1 22.12% | -34,4 |
|
EPS SEK | Released Forecast Spread | -0,50 -0,31 -60.13% | -0,67 -0,40 -69.17% | -0,81 | -0,64 -0,60 -6.67% | -0,81 -0,45 -79.66% | -0,70 -0,30 -133.33% | -0,56 -0,30 -86.67% | -0,44 -0,58 24.63% | -0,40 |
| Announcement Date | 15/03/22 | 16/06/22 | 15/12/22 | 16/03/23 | 21/06/23 | 06/09/23 | 28/11/23 | 14/03/24 | - |
| 01/05/2024 | CAREDX, INC: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | IOVANCE BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 21:05 | VERACYTE, INC.: Q1 2024 Earnings Release |
| 08/05/2024 21:05 | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 21:05 | EXACT SCIENCES CORPORATION: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | GUARDANT HEALTH, INC.: Q1 2024 Earnings Release |
| 12/05/2024 | SEEGENE, INC.: Q1 2024 Earnings Release (Projected) |
| 29/07/2024 | VERACYTE, INC.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | EXACT SCIENCES CORPORATION: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | ADAPTIVE BIOTECHNOLOGIES CORPORATION: Q2 2024 Earnings Release (Projected) |
Past sector events for Biovica International AB
| 26/04/2024 | BGI GENOMICS CO., LTD.: Q1 2024 Earnings Release |
| 12/04/2024 | BGI GENOMICS CO., LTD.: Q4 2023 Earnings Release |
| 28/02/2024 21:05 | CAREDX, INC: Q4 2023 Earnings Release |
| 28/02/2024 21:01 | IOVANCE BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release |
| 22/02/2024 21:05 | VERACYTE, INC.: Q4 2023 Earnings Release |
| 22/02/2024 21:05 | GUARDANT HEALTH, INC.: Q4 2023 Earnings Release |
| 22/02/2024 21:05 | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q4 2023 Earnings Release |
| 21/02/2024 21:05 | EXACT SCIENCES CORPORATION: Q4 2023 Earnings Release |
| 15/02/2024 | SEEGENE, INC.: Q4 2023 Earnings Release |
| 09/11/2023 | SEEGENE, INC.: Q3 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BIOVIC B Stock
- Calendar Biovica International AB
